NCT02880605View on ClinicalTrials.gov

Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization

CompletedOBSERVATIONAL
Enrollment

11,235

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions
Appropriate Use CriteriaCoronary Revascularization
Trial Locations (1)

Unknown

Fuwai Hospital, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT02880605 - Validation of Chinese Version Appropriate Use Criteria for Coronary Revascularization | Biotech Hunter | Biotech Hunter